For investors
Biotica Bio supports investment and portfolio teams with productized intelligence systems—evidence-backed where scoped, always scoped and independent.
How the three offers map to investors
Portfolio Intelligence System
Use for due diligence, new-area screening, portfolio triage, and BD-style opportunity mapping on public data.
- Target and pipeline assessment with reproducible inputs when Open Targets drives the scope
- Portfolio and pipeline review with a structured Opportunity Map mindset
- Investment-solicited and integrated thesis-style outputs align with this offer (see How it’s built)
Portfolio Intelligence System →
Visibility & Narrative System
Use as portfolio-company support: improve credibility, narrative coherence, and discoverability ahead of financing, partnering, or key hires.
Visibility & Narrative System →
Strategic Capital Options System
Use for later-stage or stressed portfolio companies when you need a structured view of non-dilutive and structured-capital paths—informational, not transactional advice.
Strategic Capital Options System →
Who this is for
- VC, crossover, and PE-backed life sciences investment teams
- Portfolio support teams needing reproducible scientific and commercial reviews
- Investment committees needing concise, auditable packages
- Strategic healthcare venture teams
Common investor outcomes
- Faster go / no-go / dig deeper with clearer downside cases
- Better portfolio prioritisation across targets or indications
- Stronger memos with transparent evidence provenance when evidence-backed scopes apply
See methodology and Portfolio Intelligence, or request scoped support.
Investor-oriented sector notes (legacy) · Diligence memo framework (legacy) · John Round — venture operator profile